GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Sunflower Pharmaceutical Group Co Ltd (SZSE:002737) » Definitions » EV-to-FCF

Sunflower Pharmaceutical Group Co (SZSE:002737) EV-to-FCF : -535.77 (As of Apr. 17, 2025)


View and export this data going back to 2014. Start your Free Trial

What is Sunflower Pharmaceutical Group Co EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Sunflower Pharmaceutical Group Co's Enterprise Value is ¥7,942 Mil. Sunflower Pharmaceutical Group Co's Free Cash Flow for the trailing twelve months (TTM) ended in Sep. 2024 was ¥-15 Mil. Therefore, Sunflower Pharmaceutical Group Co's EV-to-FCF for today is -535.77.

The historical rank and industry rank for Sunflower Pharmaceutical Group Co's EV-to-FCF or its related term are showing as below:

SZSE:002737' s EV-to-FCF Range Over the Past 10 Years
Min: -788.04   Med: 11.19   Max: 307.68
Current: -540.89

During the past 13 years, the highest EV-to-FCF of Sunflower Pharmaceutical Group Co was 307.68. The lowest was -788.04. And the median was 11.19.

SZSE:002737's EV-to-FCF is ranked worse than
100% of 546 companies
in the Drug Manufacturers industry
Industry Median: 23.125 vs SZSE:002737: -540.89

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

As of today (2025-04-17), Sunflower Pharmaceutical Group Co's stock price is ¥16.93. Sunflower Pharmaceutical Group Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2024 was ¥1.450. Therefore, Sunflower Pharmaceutical Group Co's PE Ratio (TTM) for today is 11.68.


Sunflower Pharmaceutical Group Co EV-to-FCF Historical Data

The historical data trend for Sunflower Pharmaceutical Group Co's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sunflower Pharmaceutical Group Co EV-to-FCF Chart

Sunflower Pharmaceutical Group Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only 12.49 7.63 10.84 5.68 15.99

Sunflower Pharmaceutical Group Co Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
EV-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 8.17 15.99 17.41 44.93 -780.81

Competitive Comparison of Sunflower Pharmaceutical Group Co's EV-to-FCF

For the Drug Manufacturers - Specialty & Generic subindustry, Sunflower Pharmaceutical Group Co's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sunflower Pharmaceutical Group Co's EV-to-FCF Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Sunflower Pharmaceutical Group Co's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where Sunflower Pharmaceutical Group Co's EV-to-FCF falls into.


;
;

Sunflower Pharmaceutical Group Co EV-to-FCF Calculation

Sunflower Pharmaceutical Group Co's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=7942.239/-14.824
=-535.77

Sunflower Pharmaceutical Group Co's current Enterprise Value is ¥7,942 Mil.
Sunflower Pharmaceutical Group Co's Free Cash Flow for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥-15 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Sunflower Pharmaceutical Group Co  (SZSE:002737) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

Sunflower Pharmaceutical Group Co's PE Ratio (TTM) for today is calculated as:

PE Ratio (TTM)=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=16.93/1.450
=11.68

Sunflower Pharmaceutical Group Co's share price for today is ¥16.93.
Sunflower Pharmaceutical Group Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥1.450.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


Sunflower Pharmaceutical Group Co EV-to-FCF Related Terms

Thank you for viewing the detailed overview of Sunflower Pharmaceutical Group Co's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Sunflower Pharmaceutical Group Co Business Description

Traded in Other Exchanges
N/A
Address
Welcome Road, 18 East Lake Road, Harbin High-Tech Industrial Development Zone, Harbin, Heilongjiang, CHN
Sunflower Pharmaceutical Group Co Ltd is engaged in pharmaceutical manufacturing, marketing, and scientific research. The company's product profile include Honeysuckle, Weikangling Granules, Autumn pear moisturizing cream, Vitamin AD drops, Pediatric paracetamol granules, Jianweixiaoshi tablets, Pediatric Chai Gui Antipyretic Granules, Pediatric cough syrup, Kang Fu anti-inflammatory suppository, Xiangsha Yangwei Pills, and others.
Executives
Zhou Jian Zhong Executives
Liu Tian Wei Director
Guan Yu Xiu Director
Wu Guo Xiang Executives
Ren Jing Shang Directors, executives
Guan Yan Bin Directors, executives
Wan Yun Guo Executives
Tian Yan Secretary Dong
Tan Chang Executives
Zhang Quan Director
Xu Qing Fen Supervisors
Jiang Feng He Supervisors
Wu Shu Hua Director
Guan Yan Ling Director

Sunflower Pharmaceutical Group Co Headlines

No Headlines